Abstract
We present views on the future development of biologics-based nanopharmaceuticals from a "high risk-high gain" perspective and within the context of personalized therapies. Integrated scientific, commercial, and societal aspects are addressed, and provocative combined realistic biotech, computational, and nanotech approaches for tailor-made engineering of nanopharmaceuticals are discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 8454-8458 |
| Number of pages | 5 |
| Journal | ACS Nano |
| Volume | 5 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 22 2011 |
ASJC Scopus subject areas
- Materials Science(all)
- Engineering(all)
- Physics and Astronomy(all)